BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21305450)

  • 1. [Malignant melanoma of the skin: does screening for cancer influence the incidence and mortality?].
    Schubert A
    Gesundheitswesen; 2012 Mar; 74(3):154-9. PubMed ID: 21305450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does skin cancer screening save lives? A detailed analysis of mortality time trends in Schleswig-Holstein and Germany.
    Stang A; Jöckel KH
    Cancer; 2016 Feb; 122(3):432-7. PubMed ID: 26480048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does skin cancer screening save lives?: an observational study comparing trends in melanoma mortality in regions with and without screening.
    Katalinic A; Waldmann A; Weinstock MA; Geller AC; Eisemann N; Greinert R; Volkmer B; Breitbart E
    Cancer; 2012 Nov; 118(21):5395-402. PubMed ID: 22517033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic skin cancer screening in Northern Germany.
    Breitbart EW; Waldmann A; Nolte S; Capellaro M; Greinert R; Volkmer B; Katalinic A
    J Am Acad Dermatol; 2012 Feb; 66(2):201-11. PubMed ID: 22074699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Malignant melanoma of the skin as evidenced by epidemiological cancer registries in Germany -- incidence, clinical parameters, variations in recording].
    Lehnert M; Eberle A; Hentschel S; Katalinic A; Kieschke J; Schmidtmann I; Schubert-Fritschle G; Stegmaier C; Hense HW
    Gesundheitswesen; 2005 Oct; 67(10):729-35. PubMed ID: 16235142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-based incidence rates of malignant melanoma of the vulva in Germany.
    Stang A; Streller B; Eisinger B; Jöckel KH
    Gynecol Oncol; 2005 Jan; 96(1):216-21. PubMed ID: 15589604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in the survival of patients diagnosed with malignant melanoma of the skin in the Nordic countries 1964-2003 followed up to the end of 2006.
    Tryggvadóttir L; Gislum M; Hakulinen T; Klint A; Engholm G; Storm HH; Bray F
    Acta Oncol; 2010 Jun; 49(5):665-72. PubMed ID: 20491525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Malignant melanoma: increase in incidence and mortality in West Germany].
    Garbe C; Bertz J; Orfanos CE
    Z Hautkr; 1986 Dec; 61(24):1751-64. PubMed ID: 3493596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening program reduced melanoma mortality at the Lawrence Livermore National Laboratory, 1984 to 1996.
    Schneider JS; Moore DH; Mendelsohn ML
    J Am Acad Dermatol; 2008 May; 58(5):741-9. PubMed ID: 18068264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Incidence of melanoma and changes in stage-specific incidence after implementation of skin cancer screening in Schleswig-Holstein].
    Eisemann N; Waldmann A; Katalinic A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Jan; 57(1):77-83. PubMed ID: 24357176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Disappearance of the ozone layer and skin cancer: attempt at risk assessment].
    Schaart FM; Garbe C; Orfanos CE
    Hautarzt; 1993 Feb; 44(2):63-8. PubMed ID: 8449695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin Cancer Screening in Germany. Documenting Melanoma Incidence and Mortality From 2008 to 2013.
    Katalinic A; Eisemann N; Waldmann A
    Dtsch Arztebl Int; 2015 Sep; 112(38):629-34. PubMed ID: 26429634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relation between mortality from malignant melanoma and early detection in the Cancer Research Campaign Mole Watcher Study.
    Melia J; Moss S; Coleman D; Frost T; Graham-Brown R; Hunter JA; Marsden RA; du Vivier A; Warin AP; White J; Whitehead SM; Wroughton MA
    Br J Cancer; 2001 Sep; 85(6):803-7. PubMed ID: 11556828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting early detection of malignant melanoma of the skin.
    Cooke KR; McNoe BM
    N Z Med J; 1990 Nov; 103(902):551-3. PubMed ID: 2243650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lymphomas and leukemias in population-related cancer registries in Germany].
    Lehnert M; Baumgardt-Elms C; Stegmaier C; Liese A; Krieg V; Mattauch V; Hense HW
    Gesundheitswesen; 1999 Apr; 61(4):161-7. PubMed ID: 10408142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous melanoma.
    Armstrong BK; Kricker A
    Cancer Surv; 1994; 19-20():219-40. PubMed ID: 7534627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention and early detection of cancer of the skin].
    Steinmann A; Liebl B
    Gesundheitswesen; 2004 Feb; 66 Suppl 1():S37-42. PubMed ID: 14770336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends for in situ and invasive melanoma in Queensland, Australia, 1982-2002.
    Coory M; Baade P; Aitken J; Smithers M; McLeod GR; Ring I
    Cancer Causes Control; 2006 Feb; 17(1):21-7. PubMed ID: 16411049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opportunistic screening strategy for cutaneous melanoma does not change the incidence of nodular and thick lesions nor reduce mortality: a population-based descriptive study in the European region with the highest incidence.
    Bordoni A; Leoni-Parvex S; Peverelli S; Mazzola P; Mazzucchelli L; Spitale A
    Melanoma Res; 2013 Oct; 23(5):402-7. PubMed ID: 23839077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for cutaneous melanoma.
    Lange JR; Balch CM
    Surg Oncol Clin N Am; 2005 Oct; 14(4):799-811. PubMed ID: 16226692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.